Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Yet another veteran Aetna executive ascends to the top ranks of the pharmacy chain operator.

CVS Health Names New CFO

Pharmacy chain operator CVS Health said on Tuesday it had appointed Shawn Guertin as chief financial officer, succeeding Eva Boratto who is leaving the company after 11 years.

CVS appoints Shawn Guertin as CFO, replacing Eva Boratto

WOONSOCKET, R.I., May 18, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced it has appointed Shawn Guertin as Executive Vice President and Chief Financial Officer, effective May 28, 2021.

CVS Health Appoints Shawn Guertin Chief Financial Officer

Automatic Data Processing

Franklin Resources

Domino's Pizza

Invitation Homes

Lowe's

McDonald's

Dividend growth stocks provide investors with steady top-line growth and bottom-line performance that will help fuel and sustain payouts. Here are seven deserving a close look.

7 Dividend-Paying Growth Stocks To Buy for the Best Of Both Worlds

The shares of CVS Health Corp (NYSE: CVS) have received a price target increase from $82 to $98 by Mizuho. These are the details.

CVS Health (CVS) Stock: $98 Target By Mizuho

Anthem

Cigna

Henry Schein

IQVIA Hlds

Medtronic

UnitedHealth Group

The Benzinga Global Small Cap Conference on May 13 featured presentations from publicly-traded companies and educational segments for investors. Among the featured segments was one from Chris Capre on how to trade healthcare trends.

How To Trade These 7 Healthcare Stocks and ETF Says 2ndSkiesForex's Chris Capre

The overall impact of the pandemic was a positive one for the company's Q1 results.

How COVID-19 Is Helping and Hurting CVS Health

Goldman Sachs

NIKE

Value stocks have made a big comeback this year as investors rotate out of technology and other growth securities amid heightened fears of inflation and higher interest rates. Here we look at the four best value stocks to buy now for investors who have a long-term time horizon.

4 Best Value Stocks To Buy Now for a Long-Term Horizon

WOONSOCKET, R.I., May 12, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) announced that COVID-19 vaccine appointments for adolescents ages 12 to 15 are now available for scheduling at more than 5,600 CVS Pharmacy locations nationwide, following Food and Drug Administration (FDA) Emergency Use Authorization of the Pfizer-BioNTech vaccine for this age group.

COVID-19 Vaccine Appointments Now Available for Adolescents Ages 12 to 15 at Select CVS Pharmacy Locations Nationwide

CVS Health just crushed Q1 earnings and raised earnings guidance. Traders are too focused on the stay-at-home vs. reopening stocks – CVS still flies under the radar.

CVS Stock Forecast: Why You Should Buy After Q1 Earnings

WOONSOCKET, R.I., May 11, 2021 /PRNewswire/ -- CVS Pharmacy, the retail division of CVS Health (NYSE: CVS), today announced an upgrade to its CarePass membership program, with prescription delivery within hours now free for eligible CarePass members with an eligible prescription through an expanded partnership with the delivery service Shipt.

CVS Pharmacy Upgrades Prescription Delivery Benefit for CarePass Members

CVS is currently priced as a struggling company. The prescription market is not a winner take all and investors should not be scared of AMZN's entrance.

CVS: To $100 And Beyond

CVS reported quarterly earnings last week and not only could the company beat analysts' expectations, but the top line, as well as the bottom line, grew. Despite a solid run in the last few months, the stock is still deeply undervalued and should be worth at least $135 in my opinion.

CVS Climbed Higher, But The Stock Has Still A Long Way To Go

The market has rediscovered the stock of healthcare service provider CVS Health.

CVS Health: Still Great Upside Potential

UnitedHealth Group, reported $4.9bn in profits in the first quarter of 2021 while CVS Health reported $2.2bn

US health insurers report billions in first quarter as small providers face stress

The investors were more than happy with CVS' Q1 performance as well as revised guidance, and the stock rose 4%, post the earnings announcement. Now that over 44% of the U.S. population has received at least one dose of vaccine, the company's retail sales are expected to rise, boding well for CVS.

Should You Buy CVS Health Stock After Q1 Beat?

WOONSOCKET, R.I., May 6, 2021 /PRNewswire/ -- In an ongoing effort to expand access to COVID-19 vaccines and help the country move forward from the pandemic, CVS Health (NYSE: CVS) today announced that it will begin vaccinating eligible populations on Sunday, May 9 at 19 select CVS Pharmacy locations throughout New Hampshire.

CVS Health to Administer No-Cost COVID-19 Vaccines at 19 Select CVS Pharmacy Locations in New Hampshire

Merck

SSR Mining

Bargains abound for patient long-term investors.

3 Value Stocks That'll Make You Richer in May (and Beyond)

Retail pharmacy and health care provider CVS Health Inc. ( CVS , Financial) announced revenue and earnings that edged past analyst estimates on Tuesday.

CVS Health Beats Revenue Estimates on Health Care Growth

CVS Health is looking to sell individual coverage with the “CVS-Aetna” brand under the Affordable Care Act in up to eight states for 2022.

CVS-Aetna Branded Obamacare Plans Target 8 States For 2022 Launch

CVS Health Corp. said it has recently seen a decline in the number of adults coming in for COVID-19 vaccine shots, but its outlook for the rest of the year assumes gains from the administration of pediatric vaccines.

CVS banks on future gains from pediatric vaccines as hesitant adults drive recent COVID vaccination decline

CVS Health Corporation (CVS) CEO Karen Lynch on Q1 2021 Results - Earnings Call Transcript

Before the opening bell on May 4, CVS Health Corp. ( CVS , Financial) released first-quarter 2021 results, wherein both earnings and revenue topped Wall Street's expectations due to solid retail and pharmacy service sales as more customers visited stores for Coronavirus vaccinations, tests and prescriptions.

CVS Shares Jump in Premarket Trading as Earnings Beat Estimates

CVS Health's (CVS) revenues across all the three operating segments improve in Q1. Increased guidance amid the pandemic scenario is another positive.

CVS Health (CVS) Q1 Earnings Beat Estimates, EPS View Up

CVS Health reported strong first quarter results with revenues at $69 billion, up 3.5% from the same period last year.

News for CVS Health Stock (CVS)